McKesson Corporation (BVMF:M1CK34)

Brazil flag Brazil · Delayed Price · Currency is BRL
1,111.60
+5.81 (0.53%)
At close: Apr 9, 2026
Market Cap543.20B +14.8%
Revenue (ttm)2.19T +15.5%
Net Income23.90B +53.6%
EPS191.37 +59.2%
Shares Outn/a
PE Ratio22.72
Forward PE20.32
Dividend2.87 (0.26%)
Ex-Dividend DateFeb 27, 2026
Volume36
Average Volume34
Open1,108.85
Previous Close1,105.79
Day's Range1,108.85 - 1,115.36
52-Week Range956.00 - 1,308.54
Beta0.35
RSI41.23
Earnings DateMay 7, 2026

About McKesson

McKesson Corporation provides healthcare services in the United States and internationally. It operates through four segments: U.S. Pharmaceutical, Prescription Technology Solutions (RxTS), Medical-Surgical Solutions, and International. The U.S. Pharmaceutical segment distributes branded, generic, specialty, biosimilar and over-the-counter pharmaceutical drugs, and other healthcare-related products. This segment also provides practice management, technology, clinical support, and business solutions to community-based oncology and other specialt... [Read more]

Sector Healthcare
Founded 1833
Employees 45,000
Stock Exchange Brazil Stock Exchange
Ticker Symbol M1CK34

Financial Performance

In fiscal year 2025, McKesson's revenue was $359.05 billion, an increase of 16.22% compared to the previous year's $308.95 billion. Earnings were $3.30 billion, an increase of 9.76%.

Financial numbers in USD Financial Statements

News

McKesson ideaShare 2026 Invites Independent Pharmacists to Learn, Connect and Grow

IRVING, Texas--(BUSINESS WIRE)--Registration is now open for McKesson ideaShare 2026, a premier community pharmacy event for independent pharmacy owners and their teams.

22 days ago - Business Wire

McKesson Corporation Announces Fourth Quarter Fiscal 2026 Earnings Release Date and Participation in Upcoming Conferences

IRVING, Texas--(BUSINESS WIRE)--McKesson Corporation (NYSE: MCK) will release its fourth quarter fiscal 2026 financial results after market close on Thursday, May 7, 2026. Chief Executive Officer Bria...

5 weeks ago - Business Wire

McKesson Announces Planned CFO Transition

IRVING, Texas--(BUSINESS WIRE)--McKesson Corporation (NYSE: MCK) today announced Britt Vitalone, Executive Vice President and Chief Financial Officer (CFO), has elected to retire after a successful an...

5 weeks ago - Business Wire

See How Institutional Inflows Make McKesson Fly

McKesson Corporation (MCK) shares up 58% in a year thanks to Big Money.

6 weeks ago - FXEmpire

How McKesson Stock Surged 17% In A Day

McKesson (MCK), a prominent pharmaceutical wholesaler, experienced a stock increase of 17% during a high-volume trading session. The driver for this surge was a strong Q3 earnings report that surpasse...

2 months ago - Forbes

Trump Ally Mullin Buys 10 Stocks, Including These $5 Billion Companies You've Probably Never Heard Of

Mullin reported the purchase of 10 stocks in a new disclosure, according to the Benzinga Government Trades page. The stock purchases were all made on Jan. 5, 2026, with Mullin reporting two purchases ...

2 months ago - Benzinga

McKesson boosts 2026 profit forecast amid specialty drug growth

McKesson Corporation raised its fiscal 2026 profit forecast on Wednesday, betting on strong growth in its oncology and specialty drug distribution businesses.

2 months ago - Reuters

McKesson Corporation Reports Fiscal 2026 Third Quarter Results and Raises Full Year Adjusted EPS Guidance

IRVING, Texas--(BUSINESS WIRE)--McKesson Corporation (NYSE: MCK) has released its fiscal 2026 third quarter financial results. Results can be accessed on McKesson's Investor Relations website at inves...

2 months ago - Business Wire

McKesson Corporation Completes Divestiture of Norwegian Operations

IRVING, Texas--(BUSINESS WIRE)--McKesson Corporation (NYSE: MCK) announced today that it has closed the transaction to sell its retail and distribution businesses in Norway to NorgesGruppen, a private...

2 months ago - Business Wire

McKesson Corporation Declares Quarterly Dividend

IRVING, Texas--(BUSINESS WIRE)--The Board of Directors of McKesson Corporation (NYSE: MCK) yesterday declared a regular dividend of 82 cents per share of common stock. The dividend will be payable on ...

2 months ago - Business Wire

McKesson's Practice Insights Designated as a 2026 Qualified Clinical Data Registry by Centers for Medicare & Medicaid Services

IRVING, Texas--(BUSINESS WIRE)--For the tenth year, CMS named McKesson a Qualified Clinical Data Registry approved to participate in the Merit-based Incentive Payment System.

2 months ago - Business Wire

Prudentia Sciences Announces Series A Led by McKesson Ventures, Accelerating Due Diligence for Life Sciences Dealmaking

CAMBRIDGE, Mass.--(BUSINESS WIRE)-- #AI--Prudentia Sciences, a pioneer in AI-native due diligence for life sciences dealmaking, today announced that it has secured $20 million in Series A financing. T...

3 months ago - Business Wire

Final Trades: Lockheed Martin, QXO and McKesson Corporation

CNBC's “Halftime Report” Investment Committee discuss their top stocks to watch for the second half of the day's trading session.

3 months ago - CNBC Television

Mckesson Corporation Announces Third Quarter Fiscal 2026 Earnings Release Date

IRVING, Texas--(BUSINESS WIRE)--McKesson Corporation (NYSE: MCK) will release its third quarter fiscal 2026 financial results after market close on Wednesday, February 4, 2026. The company will host a...

3 months ago - Business Wire

McKesson's Advancing Community Oncology Report Charts a New Era of Innovation for Biopharma and Community Care

IRVING, Texas--(BUSINESS WIRE)--McKesson published its first-ever Advancing Community Oncology Report, a look at the trends influencing community oncology practices across the U.S.

4 months ago - Business Wire

Final Trades: Freeport-McMoRan, Cisco, Teradyne and McKesson Corp.

The Investment Committee give you their top stocks to watch for the second half.

5 months ago - CNBC Television

McKesson raises annual profit forecast on robust demand for specialty drugs

Drug distributor McKesson raised its fiscal 2026 profit forecast on Wednesday, betting on strong growth in its oncology and specialty drug distribution businesses.

5 months ago - Reuters

McKesson Corporation Reports Fiscal 2026 Second Quarter Results and Raises Full Year Adjusted EPS Guidance

IRVING, Texas--(BUSINESS WIRE)--McKesson Corporation (NYSE: MCK) has released its fiscal 2026 second quarter financial results. Results can be accessed on McKesson's Investor Relations website at inve...

5 months ago - Business Wire

Nike and 3 More Companies Raising the Alarm About Tariff Costs

Plenty of companies will likely boost prices to protect their margins.

6 months ago - Barrons

The Market Took a Hit. These 6 Stocks Can Sidestep the Wreckage.

Those looking to buy stocks right now should look for the ones that aren't correlated to the artificial intelligence trade.

6 months ago - Barrons

How to trade the health care break out

The health care sector up 6.5% in one week. The Investment Committee debate how to trade the space.

6 months ago - CNBC Television

See How McKesson Shares Rise with Money Flows

McKesson Corporation (MCK) shares up 138.5% since Big Money bought big in May 2022.

6 months ago - FXEmpire

McKesson lifts annual profit forecast on plans to focus on high-margin businesses

McKesson on Tuesday raised its profit forecast, as the U.S. drug distributor aims to focus on high-margin businesses such as cancer medicines to boost growth.

7 months ago - Reuters

McKesson Corporation Highlights Strategic Growth Strategies and Unveils Updated Long-term Financial Targets at Investor Day

IRVING, Texas--(BUSINESS WIRE)--McKesson Corporation (NYSE: MCK) will host its 2025 Investor Day today, beginning at 9:30 AM ET. During the event, executive leadership will discuss the company's multi...

7 months ago - Business Wire

Drug distributor McKesson to restructure segments to focus on high-margin businesses

McKesson said on Thursday it will restructure its operations into four main segments from the current quarter as the U.S. drug distributor aims to focus on high-margin businesses such as cancer medici...

7 months ago - Reuters